Bringing the Oncology Community Together
Head & Neck Cancers
Minimally Invasive Esophagectomy Improves Outcomes, But Remains Underutilized
Surgery remains the most effective curative treatment for esophageal cancer. Yet, many eligible patients do not undergo esophagectomy.
Read More >>
Molecular Markers Emerge in the Diagnosis of Thyroid Cancer
Three Experts Discuss the Use of Cetuximab in Head and Neck Cancers
Immunotherapeutic Strategies in Head and Neck Cancer
Novel NGS Test May Enhance Diagnosis and Management of Indeterminate Thyroid Nodules
Next-Generation Sequencing Effectively Detects Cancer in Thyroid Nodules
Novel Therapeutic Target Identified in Aggressive Thyroid Cancers
View More >>
- A Network of Your Peers
View more >>
Importance of Multidisciplinary Thyroid Cancer Care
Dr. de Groot Discusses Altiratinib as Potential Treatment for Glioblastoma
Dr. Stupp Discusses NovoTTF With Temozolomide in Glioblastoma
Most Popular Right Now
Tweets by @OncLive
Medullary Thyroid Cancer: Advances and Challenges
Moderated by Ezra Cohen, MD, this panel discussion includes expert perspectives from Eric J. Sherman, MD, Steven I. Sherman, MD, R. Michael Tuttle, MD, and Lori J. Wirth, MD.
8th Annual Multidisciplinary Symposium on Head and Neck Cancer: Medical Crossfire
CME activity worth 2.0 CME credits led by James Tate Thigpen, MD.
American Journal of Managed Care
Oncology Nursing News
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
Terms & Conditions
666 Plainsboro Road
Plainsboro, NJ 08536
Copyright OncLive 2006-2014
Intellisphere, LLC. All Rights Reserved.